 | Aclaris Therapeutics, Inc. | |||
| NMS : ACRS || Location: United States | ||||
$1.230.0 (0.0%) |
0.65 M | 1.21 - 1.26 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.890 M |
| March 15, 2024 | 5.122 M |
| Feb. 29, 2024 | 6.099 M |
| Feb. 15, 2024 | 5.834 M |
| Jan. 31, 2024 | 6.330 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.35 | -0.02 | 94.31% |
| 09/30/2023 | -0.49 | -0.41 | 16.26% |
| 06/30/2023 | -0.46 | -0.42 | 8.50% |
| 03/31/2023 | -0.45 | -0.40 | 10.41% |
| 12/31/2022 | -0.45 | -0.41 | 9.79% |
ACRS Basic Data
| Sector | Healthcare | Industry | Diagnostics & Research |
| Shares Outstanding | 70.925M | Shares Float | 50.388M |
| Short Float | 4.890M | Market Cap | 87.24M |
| Institution ownership | 95.84% | Insider ownership | 2.782% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.27 | Forward EPS | -0.82 |